which glp-1 agonists have cardiovascular benefit in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies View of Diabetes medications with

Chronic neuroinflammation has been reported to contribute to serotonergic, dopaminergic, and noradrenergic dysfunction in the brain (Song and Wang, 2011) and to lead to chronic immune dysregulation (Carvalho et al., 2013)

These findings further underscore the notion that GLP-1R plays pivotal roles in both diseases

A qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol

Although generally safe, GLP-1RAs cause consistent GI side effects that contribute to dose interruptions and discontinuations in obesity and diabetes trials

Sustainability Concerns : The requirement for potentially lifelong therapy, combined with rapid weight regain upon discontinuation, raises questions about long-term sustainability and practical implementation

The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said in a statement